A. Aartsma-rus, A. A. Janson, and W. E. Kaman, Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients, Human Molecular Genetics, vol.12, issue.8, pp.907-914, 2003.
DOI : 10.1093/hmg/ddg100

A. Aartsma-rus, L. Van-vliet, and M. Hirschi, Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms, Molecular Therapy, vol.17, issue.3, pp.548-553, 2009.
DOI : 10.1038/mt.2008.205

B. Q. Banker, Muscular Dysgenesis in the Mouse (mdg/mdg), Journal of Neuropathology & Experimental Neurology, vol.36, issue.1, pp.100-127, 1977.
DOI : 10.1097/00005072-197701000-00010

V. Barone, F. Bertocchini, and R. Bottinelli, Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors, FEBS Letters, vol.72, issue.2, pp.160-164, 1998.
DOI : 10.1016/S0014-5793(98)00003-9

R. Benchaouir and A. Goyenvalle, Splicing Modulation Mediated by Small Nuclear RNAs as Therapeutic Approaches for Muscular Dystrophies, Current Gene Therapy, vol.12, issue.3, pp.179-191, 2012.
DOI : 10.2174/156652312800840586

A. M. Brillantes, S. Bezprozvannaya, and A. R. Marks, Developmental and tissue-specific regulation of rabbit skeletal and cardiac muscle calcium channels involved in excitation-contraction coupling, Circulation Research, vol.75, issue.3, pp.503-510, 1994.
DOI : 10.1161/01.RES.75.3.503

S. Charrier, D. Stockholm, and K. Seye, A lentiviral vector encoding the human Wiskott???Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice, Gene Therapy, vol.12, issue.7, pp.597-606, 2005.
DOI : 10.1038/sj.gt.3302440
URL : https://hal.archives-ouvertes.fr/hal-00094147

N. Chaudhari, A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice, J. Biol. Chem, vol.267, pp.25636-25639, 1992.

S. Cirak, V. Arechavala-gomeza, and M. Guglieri, Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study, The Lancet, vol.378, issue.9791, pp.595-605, 2011.
DOI : 10.1016/S0140-6736(11)60756-3

M. R. Davis, E. Haan, and H. Jungbluth, Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene, Neuromuscular Disorders, vol.13, issue.2, pp.151-157, 2003.
DOI : 10.1016/S0960-8966(02)00218-3

D. Cauwer, H. Heytens, L. , M. , and J. J. , Workshop report of the 89th ENMC International Workshop: Central Core Disease, 19th???20th January 2001, Hilversum, The Netherlands, Neuromuscular Disorders, vol.12, issue.6, pp.588-595, 2001.
DOI : 10.1016/S0960-8966(02)00002-0

F. O. Desmet, D. Hamroun, and M. Lalande, Human Splicing Finder: an online bioinformatics tool to predict splicing signals, Nucleic Acids Research, vol.37, issue.9, p.67, 2009.
DOI : 10.1093/nar/gkp215
URL : https://hal.archives-ouvertes.fr/inserm-00396239

A. Ferreiro, N. Monnier, and N. B. Romero, A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene, Annals of Neurology, vol.276, issue.11, pp.750-759, 2002.
DOI : 10.1002/ana.10231

L. Gorman, D. Suter, and V. Emerick, Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs, Proc. Natl. Acad. Sci. USA 95, pp.4929-4934, 1998.
DOI : 10.1073/pnas.95.9.4929

A. Goyenvalle, A. Vulin, and F. Fougerousse, Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping, Science, vol.306, issue.5702, pp.1796-1799, 2004.
DOI : 10.1126/science.1104297

S. M. Hammond and M. J. Wood, Genetic therapies for RNA mis-splicing diseases, Trends in Genetics, vol.27, issue.5, pp.196-205, 2011.
DOI : 10.1016/j.tig.2011.02.004

A. Herrmann-frank, M. Richter, and S. Sarkö-zi, 4-chloro- m -cresol, a potent and specific activator of the skeletal muscle ryanodine receptor, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1289, issue.1, pp.31-40, 1996.
DOI : 10.1016/0304-4165(95)00131-X

H. Jungbluth, Central core disease, Orphanet Journal of Rare Diseases, vol.2, issue.1, p.25, 2007.
DOI : 10.1186/1750-1172-2-25
URL : https://hal.archives-ouvertes.fr/inserm-00383898

G. C. Kendall, E. I. Mokhonova, and M. Moran, Dantrolene Enhances Antisense-Mediated Exon Skipping in Human and Mouse Models of Duchenne Muscular Dystrophy, Science Translational Medicine, vol.4, issue.164, pp.164-160, 2012.
DOI : 10.1126/scitranslmed.3005054

J. Kyselovic, J. J. Leddy, and A. Ray, Temporal differences in the induction of dihydropyridine receptor subunits and ryanodine receptors during skeletal muscle development, J. Biol. Chem, vol.269, pp.21770-21777, 1994.

J. Krebs, The influence of calcium signaling on the regulation of alternative splicing, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.6, pp.979-984, 2009.
DOI : 10.1016/j.bbamcr.2008.12.006

J. T. Lanner, D. K. Georgiou, A. D. Joshi, H. , and S. L. , Ryanodine Receptors: Structure, Expression, Molecular Details, and Function in Calcium Release, Cold Spring Harbor Perspectives in Biology, vol.2, issue.11, p.3996, 2010.
DOI : 10.1101/cshperspect.a003996

J. M. Lee, S. H. Rho, and D. W. Shin, Negatively Charged Amino Acids within the Intraluminal Loop of Ryanodine Receptor Are Involved in the Interaction with Triadin, Journal of Biological Chemistry, vol.279, issue.8, pp.6994-7000, 2004.
DOI : 10.1074/jbc.M312446200

S. Lorain, C. Peccate, L. Hir, M. Garcia, and L. , Exon Exchange Approach to Repair Duchenne Dystrophin Transcripts, PLoS ONE, vol.8, issue.5, 2010.
DOI : 10.1371/journal.pone.0010894.s004

P. J. Lynch, J. Tong, and M. Lehane, A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca 2 + release channel function and severe central core disease, Proc. Natl. Acad. Sci. USA 96, pp.4164-4169, 1999.

I. Marty, M. Robert, and M. Villaz, Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle., Proc. Natl. Acad. Sci. USA 91, pp.2270-2274, 1994.
DOI : 10.1073/pnas.91.6.2270

N. Monnier, N. B. Romero, and J. Lerale, Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.10, issue.22, pp.2581-2592, 2001.
DOI : 10.1093/hmg/10.22.2581

N. Monnier, A. Ferreiro, and I. Marty, A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia, Human Molecular Genetics, vol.12, issue.10, pp.1171-1178, 2003.
DOI : 10.1093/hmg/ddg121

N. Monnier, I. Marty, and J. Faure, Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores, Human Mutation, vol.130, issue.5, pp.670-678, 2008.
DOI : 10.1002/humu.20696
URL : https://hal.archives-ouvertes.fr/inserm-00381934

L. Naldini, Lentiviruses as gene transfer agents for delivery to non-dividing cells, Current Opinion in Biotechnology, vol.9, issue.5, pp.457-463, 1998.
DOI : 10.1016/S0958-1669(98)80029-3

F. Pietri-rouxel, C. Gentil, and S. Vassilopoulos, DHPR ??1S subunit controls skeletal muscle mass and morphogenesis, The EMBO Journal, vol.4, issue.3, pp.643-654, 2010.
DOI : 10.1016/j.cmet.2007.11.004
URL : https://hal.archives-ouvertes.fr/ensl-00817432

G. A. Porter, . Jr, R. F. Makuck, R. , and S. A. , Reduction in Intracellular Calcium Levels Inhibits Myoblast Differentiation, Journal of Biological Chemistry, vol.277, issue.32, pp.28942-28947, 2002.
DOI : 10.1074/jbc.M203961200

J. S. Reuter and D. H. Mathews, RNAstructure: software for RNA secondary structure prediction and analysis, BMC Bioinformatics, vol.11, issue.1, 2010.
DOI : 10.1186/1471-2105-11-129

S. S. Rezgui, S. Vassilopoulos, and J. Brocard, Triadin (Trisk 95) Overexpression Blocks Excitation-Contraction Coupling in Rat Skeletal Myotubes, Journal of Biological Chemistry, vol.280, issue.47, pp.39302-39308, 2005.
DOI : 10.1074/jbc.M506566200
URL : https://hal.archives-ouvertes.fr/inserm-00381760

N. B. Romero, N. Monnier, and L. Viollet, Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia, Brain, vol.126, issue.11, pp.2341-2349, 2003.
DOI : 10.1093/brain/awg244
URL : http://doi.org/10.1093/brain/awg244

N. Roux-buisson, J. Rendu, and I. Denjoy, Functional analysis reveals splicing mutations of the CASQ2 gene in patients with CPVT: implication for genetic counselling and clinical management, Human Mutation, vol.358, issue.9, pp.995-999, 2011.
DOI : 10.1002/humu.21537
URL : https://hal.archives-ouvertes.fr/inserm-00644146

S. Seigneurin-venin, E. Parrish, and I. Marty, Involvement of the Dihydropyridine Receptor and Internal Ca2+Stores in Myoblast Fusion, Experimental Cell Research, vol.223, issue.2, pp.301-307, 1996.
DOI : 10.1006/excr.1996.0085

P. Spitali and A. Aartsma-rus, Splice Modulating Therapies for Human Disease, Cell, vol.148, issue.6, pp.1085-1088, 2012.
DOI : 10.1016/j.cell.2012.02.014

H. Takeshima, M. Iino, and H. Takekura, Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene, Nature, vol.369, issue.6481, pp.556-559, 1994.
DOI : 10.1038/369556a0

M. Taniguchi-ikeda, K. Kobayashi, and M. Kanagawa, Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy, Nature, vol.9, issue.7367, pp.127-131, 2011.
DOI : 10.1038/nature10456

P. Tarroni, D. Rossi, A. Conti, V. Sorrentino, . Et et al., Expression of the Ryanodine Receptor Type 3 Calcium Release Channel during Development and Differentiation of Mammalian Skeletal Muscle Cells, Journal of Biological Chemistry, vol.272, issue.32, pp.19808-19813, 1997.
DOI : 10.1074/jbc.272.32.19808

L. E. Taylor, Y. J. Kaminoh, C. K. Rodesch, and K. M. Flanigan, Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens, Neuropathology and Applied Neurobiology, vol.378, issue.6, pp.591-601, 2012.
DOI : 10.1111/j.1365-2990.2012.01250.x

A. Vulin, I. Barthelemy, and A. Goyenvalle, Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping, Molecular Therapy, vol.20, issue.11, pp.2120-2133, 2012.
DOI : 10.1038/mt.2012.181

N. Wein, A. Avril, and M. Bartoli, Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping, Human Mutation, vol.56, issue.2, pp.136-142, 2010.
DOI : 10.1002/humu.21160

T. M. Wheeler, J. D. Lueck, and M. S. Swanson, Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy, Journal of Clinical Investigation, vol.117, pp.3952-3957, 2007.
DOI : 10.1172/JCI33355

H. Zhou, H. Jungbluth, and C. A. Sewry, Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies, Brain, vol.130, issue.8, pp.2024-2036, 2007.
DOI : 10.1093/brain/awm096

M. Zuker, Mfold web server for nucleic acid folding and hybridization prediction, Nucleic Acids Research, vol.31, issue.13, pp.3406-3415, 2003.
DOI : 10.1093/nar/gkg595